33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135693
178559
2
Create a timeline
Public Timelines
For educational institutions For teachers For students Cabinet
For educational institutions For teachers For students Open cabinet
FAQ Ricevere il Premium
Create a timeline
Public timelines
FAQ
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate

28 sett 2017 anni - FDA sent letters to IR opioid analgesic manufacturers informing them that their products that are intended to be used in the outpatient setting will be subject to the same REMS requirements as the ER/LA opioid analgesics.

Aggiunto al nastro di tempo:

Opioids and the FDA

ByAnastasia
13 nov 2018
0
0
520

Data:

28 sett 2017 anni
Adesso
~ 8 years ago
About & FeedbackAccordoPrivatezzaFAQ
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL